Sixty-two patients of two institutions for mentally retarded patients were immunized intradermally with 4 micrograms doses of plasma-derived hepatitis B vaccine made in Japan, initially at month 0.1 and 6. The three vaccinations induced antibodies in 93.5% (90.9% in those with Down's syndrome (DS),
Cost effectiveness of intradermal vs. subcutaneous hepatitis b vaccination for the mentally handicapped
β Scribed by Jun Hayashi; Koya Nakashima; Akinori Noguchi; Miki Morofuji; Seizaburo Kashiwagi
- Publisher
- Elsevier Science
- Year
- 1991
- Tongue
- English
- Weight
- 375 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0163-4453
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In order to determine the prevalence of hepatitis B virus (HBV) markers, 400 patients were studied: 134 residents of an institution (RI) for the mentally retarded and 266 under non-residential care (NRC). In the residential institutions, all markers were absent in 69 (65.7%) of 105 patients with Dow
## Treatment of chronic hepatitis C with Interferon (IFN) β£2b monotherapy results in 10% to 15% sustained virological response (SVR). Combining IFN with ribavirin increases this response. In this analysis, using the Markov model, 6 treatment strategies for chronic hepatitis C (previously untreated